Nashville

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Glioblastoma1 trial
• Multiple myeloma1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Bristol-Myers Squibb1 trial
• Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial

Running trials

• Recruiting

  A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

  NCT06153251· Phase 1· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

  Contact: Site 0008

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma1 recruiting

Closed trials

• Completed

  An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

  NCT02667587· Phase 3· Bristol-Myers Squibb· Source